It’s Never Too Soon: How and When to Engage Medical Affairs
Engagement with Medical Affairs is critical at every juncture in the drug development process, with Medical Affairs acting as a key liaison between internal stakeholders, a new generation of physicians, and patient advocates...
Read MoreTop Stories
It’s Never Too Soon: How and When to
Engagement with Medical Affairs is critical at every...
Celebrating Health Literacy Month 2024:
October is Health Literacy Month, a reminder of the...
Celebrating World Patient Safety Day 2024:
On World Patient Safety Day 2024, we focus on the critical...
Filter
Medical Device Manufacturing: Risk-Based QMS Alignment for EU MDR
The latest EU-MDR guidelines are a step in the right direction, moving from a focus...
Why Do Plain Language Clinical Trial Summaries Matter?
Did you know that the European Medicines Agency’s Clinical Trials Regulation comes into effect on...
MedTech Summit 2021: Understanding Post Market Clinical Follow Up (PCMF)
An ideal PMCF plan, with reference to MDCG 2020-7, presents the general and specific methods...
Bringing New Devices to Market under the EU MDR
With the MDR coming into effect, the manufacturers should plan and construct their strategy to...
A Summarized Report of the Virtual MedTech EU MDR Exchange Conference
Session summaries from EUMDR exchange conference 2021...
How to Incorporate and Drive Equity, Diversity, and Inclusion in Medical Communications and Publications
A roadmap on how to drive advocacy for EDI in medical communications and publications and...